Pharmaron Beijing Co., Ltd — Board/Management Information 2020

Jul 23, 2020

==> picture [117 x 33] intentionally omitted <==

Pharmaron Beijing Co., Ltd. 康龍化成（北京）新藥技術股份有限公司*

(a joint stock company incorporated in the People’s Republic of China with limited liability)

(Stock Code: 3759)

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

The members of the board of directors (the “Board”) of Pharmaron Beijing Co., Ltd. (the “Company”) are set out below:

Executive Directors

Dr. LOU Boliang (chairman of the Board)

Mr. LOU Xiaoqiang

Ms. ZHENG Bei

Non-executive Directors

Mr. CHEN Pingjin Mr. HU Baifeng

Mr. LI Jiaqing

Mr. ZHOU Hongbin

Independent non-executive Directors

Mr. DAI Lixin

Ms. CHEN Guoqin

Mr. TSANG Kwan Hung Benson

Mr. YU Jian

There are four Board committees.

The Company will convene the first meeting of the second session of the Board on July 28, 2020, during which members and chairmen of four Board committees will be elected. The Company will announce the composition of the Board committees in due course.

Beijing, the PRC July 23, 2020

• For identification purposes only